This latest interview is excellent and David provides a clear explanation of the advantages we gained with Fast Track approval. It can't be easy to face delicate political questions about Biotechs working with the new FDA in a public forum; yet David is as reassuring about ATH's position as he is candid and honest. For all the political uncertainties that abound right now, David has steered us into a great position to get this seriously moving.
This latest interview is excellent and David provides a clear...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 3326523 | 3 |
View Market Depth
| Last trade - 09.45am 31/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable